ATIVESITE | Capitol Hill Briefing on LDTs

During a Capitol Hill briefing for congressional staffers that took place July 9, the CAP discussed how Congress can promote patient safety without overburdening laboratories through enacting a diagnostic reform package that provides oversight of laboratory-developed tests (LDTs) while still allowing for innovation of new technologies and patient access to accurate testing. The Capitol Hill briefing featured top pathologists from around the country who provided background on LDTs and answered questions from congressional staffers.

Donald Karcher, MD, FCAP, the CAP’s President and Joe Saad, MD, FCAP, President, Surgical Pathologists of Dallas presented congressional staff with CAP’s concerns that the FDA is moving forward with its regulatory oversight plan for LDTs without making the additional changes needed to ensure both patient safety and access to accurate and innovative testing.

Source College of American Pathologists YouTube